Receptor Antagonists of insulin-like Growth Factor (IGF - IR) as Auxiliary Treatment of Prostate Cancer

摘要

The present Invention relates to a method for treating Prostate Cancer With androgen deprivation Therapy and a receptor antagonist of insulin like growth factor (IGF - IR).Although the speed of response of Prostate Cancer to androgen deprivation Therapy (ADT) is high, the cancer cells that survive invariably become androgen Independent (AI) and follows the growth of the tumor.The Invention Inhibits or delays the transition of androgen dependent cancer androgen Independent cancer, significantly reduces the risk of recurrence, and improve the Treatment Outcome.